Thrivent Financial for Lutherans
ABMD

Thrivent Financial for Lutherans’s Abiomed Inc ABMD Stock Holding History

Thrivent Financial for Lutherans’s Portfolio ABMD Stock Details ABMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-2,022
Closed -$497K – 2480
2022
Q3 		$497K Buy
2,022
+14
+0.7% +$3.78K ﹤0.01% 2072
2022
Q2 		$497K Sell
2,008
-2,900
-59% -$783K ﹤0.01% 2096
2022
Q1 		$1.71M Buy
4,908
+2,914
+146% +$897K ﹤0.01% 1440
2021
Q4 		$716K Sell
1,994
-4,365
-69% -$1.47M ﹤0.01% 2039
2021
Q3 		$2.01M Sell
6,359
-4
-0.1% -$1.35K ﹤0.01% 1350
2021
Q2 		$1.99M Buy
6,363
+18
+0.3% +$5.52K ﹤0.01% 1432
2021
Q1 		$2.02M Sell
6,345
-9
-0.1% -$2.88K ﹤0.01% 1421
2020
Q4 		$2.06M Buy
6,354
+1,035
+19% +$286K ﹤0.01% 1298
2020
Q3 		$1.47M Sell
5,319
-1,127
-17% -$325K ﹤0.01% 1338
2020
Q2 		$1.14M Buy
6,446
+18
+0.3% +$3.61K ﹤0.01% 1417
2020
Q1 		$933K Buy
6,428
+3
+0% +$498 ﹤0.01% 1347
2019
Q4 		$1.1M Sell
6,425
-17,251
-73% -$3.2M ﹤0.01% 1410
2019
Q3 		$4.21M Sell
23,676
-21,249
-47% -$4.59M 0.01% 730
2019
Q2 		$11.7M Buy
44,925
+136
+0.3% +$36.1K 0.04% 469
2019
Q1 		$12.8M Buy
44,789
+894
+2% +$297K 0.04% 420
2018
Q4 		$14.8M Buy
43,895
+27,910
+175% +$9.7M 0.05% 360
2018
Q3 		$7.19M Buy
15,985
+799
+5% +$315K 0.02% 571
2018
Q2 		$6.21M Sell
15,186
-33,566
-69% -$12.2M 0.02% 613
2018
Q1 		$14.2M Sell
48,752
-21,183
-30% -$5.37M 0.05% 380
2017
Q4 		$13.1M Sell
69,935
-10,505
-13% -$1.96M 0.04% 387
2017
Q3 		$13.6M Sell
80,440
-5,980
-7% -$904K 0.05% 343
2017
Q2 		$12.4M Sell
86,420
-32,520
-27% -$4.37M 0.05% 334
2017
Q1 		$14.9M Buy
118,940
+21,740
+22% +$2.52M 0.06% 288
2016
Q4 		$11M Sell
97,200
-10,820
-10% -$1.25M 0.05% 355
2016
Q3 		$13.9M Sell
108,020
-8,520
-7% -$1.02M 0.06% 303
2016
Q2 		$12.7M Buy
116,540
+9,850
+9% +$980K 0.06% 315
2016
Q1 		$10.1M Sell
106,690
-6,990
-6% -$590K 0.05% 355
2015
Q4 		$10.3M Buy
113,680
+46,360
+69% +$3.93M 0.05% 332
2015
Q3 		$6.25M Buy
67,320
+9,350
+16% +$824K 0.03% 466
2015
Q2 		$3.81M Buy
57,970
+44,320
+325% +$2.94M 0.02% 539
2015
Q1 		$977K Buy
13,650
+300
+2% +$16.3K 0.01% 845
2014
Q4 		$508K Buy
13,350
+150
+1% +$4.73K ﹤0.01% 1107
2014
Q3 		$328K Buy
13,200
+300
+2% +$7.6K ﹤0.01% 1323
2014
Q2 		$324K Sell
12,900
-108,500
-89% -$2.53M ﹤0.01% 1359
2014
Q1 		$3.16M Buy
121,400
+108,600
+848% +$3M 0.02% 512
2013
Q4 		$342K Hold
12,800
– – ﹤0.01% 1193
2013
Q3 		$244K Sell
12,800
-100
-0.8% -$2.29K ﹤0.01% 1341
2013
Q2 		$278 Buy
+12,900
New +$259K ﹤0.01% 1245

Other funds holding ABMD

TRSOTSOK
Teachers Retirement System of the State of Kentucky Frankfort, Kentucky $12.9B AUM 31.03% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return
Rockefeller Capital Management
Rockefeller Capital Management New York $56.4B AUM 24.96% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return
AW
Avion Wealth The Woodlands, Texas $484M AUM 15.17% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Thrivent Financial for Lutherans's ABMD Position: Q4 2022 in Review

Thrivent Financial for Lutherans sold out of Abiomed Inc (ABMD) in Q4 2022, closing a stake of 2,022 shares — an estimated $497K sold.

Thrivent Financial for Lutherans first reported a position in ABMD in Q2 2013 and held it in 38 quarters. The position peaked at $14.9M in Q1 2017. 8 funds tracked by Wall St. Rank hold ABMD as of Q4 2022.

  • Thrivent Financial for Lutherans reported no remaining Abiomed Inc position as of Q4 2022 after selling out during the quarter.
  • Thrivent Financial for Lutherans sold 2,022 Abiomed Inc shares in Q4 2022, an estimated $497K.
  • Thrivent Financial for Lutherans first reported a position in Abiomed Inc in Q2 2013 and held it in 38 quarters.
  • Thrivent Financial for Lutherans's Abiomed Inc position peaked at $14.9M in Q1 2017.
  • 8 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2022.

Based on Thrivent Financial for Lutherans's 13F filing for Q4 2022, filed 8 Feb 2023.